About Careers MedBlog Contact us

Malaria Drug to Treat Pancreatic Cancer

by Dr. Trupti Shirole on March 16, 2011 at 8:11 PM
Font : A-A+

 Malaria Drug to Treat Pancreatic Cancer

Using hydroxychloroquine a team of US scientists at the Dana-Farber Cancer Institute have successfully managed to slow down the growth of pancreatic tumor in mice.

This drug was originally developed to treat malaria. Later scientists discovered its mild suppressing activity on the immune system and began using hydroxychloroquine in autoimmune diseases. As immune system suppressants inhibit the process of autophagy which is elevated in cancer patients, researchers showed interest in the drug. Autophagy is a process which helps the cells to survive or adapt to treatments like chemotherapy by helping the cells convert non-critical proteins into nutrients. In early laboratory tests it was revealed that the drug decreased growth among the tumor cells, which suggests that the cells further rely on autophagy for their growth.


These results have been encouraging and led to the opening of two new clinical trials in patients with advanced pancreatic cancer.

Source: Medindia

Recommended Reading

open close


Malaria Drug to Treat Pancreatic Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests